Position in NVO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,217,100
+$133,784 QoQ
Shares Held
25,388
-13.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#480
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clean Yield Group holds $24,144,095 across 11 Drug Manufacturers - General names. NVO ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
158,720 | $8,320,102 | |
| 2 | JNJ |
Johnson & Johnson
|
19,963 | $5,070,003 | |
| 3 | LLY |
ELI LILLY & Co
|
3,179 | $3,812,988 | |
| 4 | AMGN |
Amgen Inc
|
5,626 | $2,037,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,182 | $1,822,387 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
25,388 | $1,217,100 | |
| 7 | ABBV |
AbbVie Inc.
|
3,891 | $979,131 | |
| 8 | AZN |
Astrazeneca PLC
|
2,950 | $559,379 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,217,100 | 25,388 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,083,316 | 29,478 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,533,574 | 30,141 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,672,524 | 30,141 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,176,269 | 31,531 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,296,797 | 33,076 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,914,013 | 33,876 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $4,094,341 | 34,386 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,020,165 | 35,170 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $4,630,360 | 36,062 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $4,129,413 | 39,917 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,706,896 | 40,762 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,104,061 | 19,181 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $3,180,572 | 19,986 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,892,351 | 21,371 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,168,546 | 21,766 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,436,528 | 21,866 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,515,948 | 22,656 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,098,256 | 27,663 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,714,874 | 28,277 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,403,947 | 28,697 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $2,152,855 | 31,932 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,372,245 | 33,962 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,443,380 | 35,192 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,362,191 | 36,075 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,004,762 | 49,913 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||